Shape therapeutics stock
Webbför 9 timmar sedan · Pear Therapeutics (NASDAQ: PEAR) stock is falling on Friday after the company’s recent bankruptcy filing continues to weigh on its shares. Pear Therapeutics … Webb18 dec. 2024 · Shape Therapeutics, Inc. USPTO Trademarks › Shape Therapeutics, Inc. › Shapetx Application #90394153. Application Filed: 2024-12-18. Trademark Application Details. The mark consists of the word Shape with initial capital letter S followed by the smaller capital letters TX appearing as a superscript.
Shape therapeutics stock
Did you know?
Webb16 juli 2024 · Shape Therapeutics, a Seattle preclinical stage biotech company developing RNA editing and gene therapy technologies, has raised $112 million. The company’s RNA … WebbComprised of a team of skilled scientists, molecular engineers, and industry veterans in addition to a world class Board, we are well-suited for the challenge of bringing the promise of our oRNATMtherapeutics to patients. Leadership Board of Directors Investors Leadership Thomas Barnes, PhD
Webb10 okt. 2024 · The preclinical-stage biotech company Shape Therapeutics (ShapeTX), based in Seattle, Washington, is using artificial intelligence and machine learning to develop RNA-based therapies that are... WebbWhat happened Nurix Therapeutics (NASDAQ: NRIX) stock soared more than 21% on Wednesday. UPDATE - Shape Therapeutics to Present the Discovery of MOSCOW (Reuters) -Russia has demanded that 13 foreign and mostly U.S. technology companies be officially represented on Russian soil by the end of 2024 or face possible restrictions or outright …
Webb15 juli 2024 · Shape Therapeutics's latest funding round was a Series B for $112M on July 15, 2024. View all funding This profile has not been claimed. You're more than your latest funding, tell our customers your company's story. Submit Your Analyst Briefing Shape Therapeutics Investors 5 Investors Shape Therapeutics has 5 investors. Webb14 apr. 2024 · Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today …
WebbShapeTX Stock. shapetx.com Healthcare Founded: 2024 Funding to Date: $138.25MM. Shape Therapeutics is a biotechnology company focused on developing breakthrough …
Webb9 nov. 2024 · The startups have collectively raised more than $320 million, although ReCode and Shape are also working on other RNA-based technologies. Tevard and … smallest moon of jupiterWebbROME Therapeutics – A new frontier in biology ... Explore smallest money in the worldWebbFunding. Shape Therapeutics has raised a total of $147.5M in funding over 2 rounds. Their latest funding was raised on Jul 15, 2024 from a Series B round. Shape Therapeutics is funded by 8 investors. New Enterprise Associates … song mary did you know who wrote itWebbThe Shield Therapeutics PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at 6.44p. The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share. song mary don\u0027t you weepWebbTG Therapeutics stock price target cut to $35 from $49 at B. Riley. Feb. 23, 2024 at 7:44 a.m. ET by Tomi Kilgore. smallest monitor that can run 240hzWebb30 nov. 2024 · Shape Therapeutics is not exactly a new company. It was founded in 2024, but the viability of the concept the company has been working on only became clearer recently. In November, the company... smallest monument in the worldWebb6 apr. 2024 · 3 brokerages have issued 1 year price objectives for Achilles Therapeutics' shares. Their ACHL share price forecasts range from $8.00 to $12.00. On average, they expect the company's share price to reach $10.00 in the next twelve months. This suggests a possible upside of 963.8% from the stock's current price. song mary did you know with lyrics